Literature DB >> 16921079

Sedation practice in a Scottish teaching hospital emergency department.

R A Duncan1, L Symington, S Thakore.   

Abstract

OBJECTIVES: To conduct a prospective survey in a teaching hospital emergency department to evaluate performance according to safe sedation principles, to establish the demographics of those sedated, and to review the drugs used and doses given to patients in the department. Any adverse events were reviewed for identification of preventable causes.
METHODS: Pre-sedation checklists, peri-procedural observations, and patient notes were reviewed for 101 cases from 4 December 2004 to 3 September 2005. There are departmental guidelines outlining the principles of safe sedation.
RESULTS: Emergency department procedural sedation was performed for a variety of acute conditions in patients aged from 7 to 91 years old. A variety of sedation agents were administered, morphine and midazolam being used most frequently. Drug administration, maximum sedation level, and time to recovery and discharge were recorded. Four adverse events were reported, none of which were clinically significant. Departmental guidelines were followed.
CONCLUSION: Emergency department sedation is a safe and effective procedure if appropriately trained practitioners follow the principles of safe sedation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16921079      PMCID: PMC2564208          DOI: 10.1136/emj.2006.035220

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  10 in total

Review 1.  Pulmonary aspiration risk during emergency department procedural sedation--an examination of the role of fasting and sedation depth.

Authors:  Steven M Green; Baruch Krauss
Journal:  Acad Emerg Med       Date:  2002-01       Impact factor: 3.451

2.  Practice guidelines for sedation and analgesia by non-anesthesiologists.

Authors: 
Journal:  Anesthesiology       Date:  2002-04       Impact factor: 7.892

Review 3.  Midazolam: a review of therapeutic uses and toxicity.

Authors:  S P Nordt; R F Clark
Journal:  J Emerg Med       Date:  1997 May-Jun       Impact factor: 1.484

Review 4.  Clinical policy: procedural sedation and analgesia in the emergency department.

Authors:  Steven A Godwin; David A Caro; Stephen J Wolf; Andy S Jagoda; Ronald Charles; Benjamin E Marett; Jessie Moore
Journal:  Ann Emerg Med       Date:  2005-02       Impact factor: 5.721

5.  Midazolam-fentanyl intravenous sedation in children: case report of respiratory arrest.

Authors:  M Yaster; D G Nichols; J K Deshpande; R C Wetzel
Journal:  Pediatrics       Date:  1990-09       Impact factor: 7.124

6.  Prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing, and sedation methods.

Authors:  M A Quine; G D Bell; R F McCloy; J E Charlton; H B Devlin; A Hopkins
Journal:  Gut       Date:  1995-03       Impact factor: 23.059

7.  A clinical trial of propofol vs midazolam for procedural sedation in a pediatric emergency department.

Authors:  C J Havel; R T Strait; H Hennes
Journal:  Acad Emerg Med       Date:  1999-10       Impact factor: 3.451

Review 8.  Procedural sedation and analgesia in the emergency department: what are the risks?

Authors:  Michael A Miller; Phillip Levy; Manish M Patel
Journal:  Emerg Med Clin North Am       Date:  2005-05       Impact factor: 2.264

9.  Procedural sedation and analgesia in the emergency department. Canadian Consensus Guidelines.

Authors:  G Innes; M Murphy; C Nijssen-Jordan; J Ducharme; A Drummond
Journal:  J Emerg Med       Date:  1999 Jan-Feb       Impact factor: 1.484

10.  Intravenous sedation in accident and emergency departments: a nationwide survey.

Authors:  B H Aslam; I Woods
Journal:  Ann R Coll Surg Engl       Date:  1994-01       Impact factor: 1.891

  10 in total
  2 in total

1.  Sedate with caution.

Authors:  J M Lutz; W F de Mello
Journal:  Emerg Med J       Date:  2007-01       Impact factor: 2.740

2.  Propofol for procedural sedation in the emergency department.

Authors:  Tamsin Dunn; David Mossop; Alastair Newton; Alison Gammon
Journal:  Emerg Med J       Date:  2007-07       Impact factor: 2.740

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.